Expert debate Expert debate Expert talks and scientific presentations by local and international clinicians and scientists. Published: 23 Oct 2022

Unmet needs and recent advances in the management of neuropathic pain

Three specialists discuss unmet medical needs in neuropathic pain, and share expert guidance that could improve clinical outcomes for these patients.

Dr Bouhassira listed that he is/was a consultant/advisor for Bayer AG and Grünenthal B.V.. He listed as well that the is/was research grant recipient from Bayer AG, Grünenthal B.V., and Novartis.

Dr Dickenson listed that he was a speaker on a speaker's bureau for Grünenthal UK and Portugal.

Dr Freeman listed that he is/was a consultant/advisor for AlgoRx, Allergan, Clexio, Collegium, Glenmark, GW Pharma, Glaxo-Smith Kline, Eli Lilly, Lundbeck, Maxona, Novartis, Vertex, and Worwag. He listed stock ownership from Applied Therapeutics, Cutaneous NeuroDiagnostics, NeuroBo, and Regenacy.

Learn more

Digital Health Pain COVID-19 TRPA1 blocker neuromodulatory systems Sensory phenotype individualized care EMG ion channel AAPT Telemedicine individualized treatment rTMS neuropathic QST NPSI Personalized medicine deep brain stimulation Biofeedback Spinal Cord Stimulation neuropathic pain Stratification Diagnostic criteria